Global Tuberculosis Diagnostics
Market Report
2025
Tuberculosis Diagnostics market size will be $3.32 Billion by 2030, whereas its compound annual growth rate with be 6.03% from 2024 to 2031.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Tuberculosis Diagnostics Market Report 2025.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Tuberculosis Diagnostics Market Sales Revenue | 121212 | 121212 | 121212 | 6.03% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Tuberculosis Diagnostics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Tuberculosis Diagnostics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
According to Cognitive Market Research, the Global Tuberculosis Diagnostics market size will be $3.32 Billion by 2030, whereas its compound annual growth rate with be 6.03% from 2024 to 2031. The disease Tuberculosis is caused by the effect on the lungs by a type of bacteria. The Tuberculosis test of the skin (TST) and Tuberculosis blood tests are the two varieties of tests used to identify TB germs in the body. Only the presence of Tuberculosis bacteria in an individual is indicated by a test of TB which is positive or a TB blood test. Inside one forearm, a tiny amount of a drug known as tuberculin is injected. A medical professional will examine your arm at the injection point for swelling within 47 to 72 hours. The result of positive or negative is determined by the area of the skin that is raised. The market for Tuberculosis Diagnostics is expected to grow as there are increasing number of patients with this disease. For Instance, According to WHO, Globally, 10.6 million cases of tuberculosis were reported in 2022. For the prevention, diagnosis, treatment, and care, US$ 13 billion is required yearly to reach the worldwide target set at the 2018 UN high-level summit on TB. Along with this, the awareness and control of this diagnosis are on the rise. There is also the commercialization of a variety of products that boosts the growth of the market. Initiatives taken by governments for the prevention of disease surge the demand for Tuberculosis Diagnostics. The increase in Tuberculosis and MDR-TB Cases globally largens the market for Tuberculosis Diagnostics are the key drivers in this market. Overall, it is a growing market that has scope in the future as the healthcare sector is on the rise.
For the development of the country and to reduce the number of patients suffering from tuberculosis, governments have taken initiatives like policy implementation, increasing awareness, and providing necessary factors. Several people opt for treatment from the private sector but there remains a group of people who are not able to afford such expensive treatments. Here the government has to step in to help provide quality health services that are also accessible for all. It not only protects the workers financially but also ensures that they are protected from unfair treatment and have the right to good health. For Instance, The "Differentiated Care of TB Patients" initiative is being carried out by World Health Partners (WHP) and John Snow, Inc. The initiative is being implemented in Uttar Pradesh's high-notification public health facilities in the districts of Barabanki, Unnao, Kanpur, and Lucknow. To lower morbidity and avoidable death among TB patients, the project will design and implement a complete package of diagnostic and referral services across multiple healthcare facilities.(Source:https://worldhealthpartners.org/tifa.php?page=project) The treatment of tuberculosis consists of blood tests, Skin tests, X-rays, Sputum tests combination of medicines for antibacterial drugs which have to be taken for 6-12 months. This treatment can be done by people who can afford to do the above-mentioned tests and take the medicines. For example, from the standpoints of the health system and society, the unit cost of a tuberculosis diagnosis per individual was USD 27.22 and USD 70.16, respectively.
(Source:http://system and society, the unit cost of a tuberculosis diagnosis per individual was USD 27.22 and USD 70.16) ,So to solve the problem of funding, Government initiatives help them in terms of financing. For Instance, For India's "TB Mukt Bharat" objective to be successful, funding for healthcare is essential. A robustly financially supported healthcare system will protect the interests of marginalized and vulnerable groups, including women, children, and rural residents. Therefore, due to all reasons, Government initiatives play a role in the improvement of health care and facilitating the people for their betterment.
The increase in Tuberculosis and MDR-TB Cases globally boosts the market for Tuberculosis Diagnostics
One of the main drivers for this market is the crucial increase in cases of tuberculosis. According to WHO, after COVID-19, tuberculosis is the second most common infectious killer globally, surpassing HIV and AIDS. 10.6 million cases of tuberculosis (TB) are there globally in 2022. The reasons for this disease if high blood sugar levels, malnourished, or a weak immune system. Low-income and middle-income countries have over 80% of tuberculosis cases and deaths and in 2021, 30 countries had high tuberculosis rates and 87.0% of new cases. Thus, there is a need globally for the treatment of this disease. A bacterium that is driven to a minimum of isoniazid and rifampin, the two most effective TB medications, is the source of multidrug-resistant tuberculosis (MDR TB)
(Source:https://www.who.int/news-room/fact-sheets/detail/tuberculosis#:~:text=Worldwide%2C%20TB%20is%20the%20second,all%20countries%20and%20age%20groups)All patients with tuberculosis are treated with these medications. The MDR-TB is a multi-drug resistant Tuberculosis, there is an increase in this multi-drug resistance because of ill-treatment and mismanaging the Tuberculosis treatment. Not using the drugs correctly or poor quality of drugs leads to cause in drug resistance. This can then be easily transmitted from person to person in any public area or hospital. For Instance, According to WHO’s most recent anti-TB drug resistance surveillance statistics, multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) is thought to be present in 3.5% of new cases of TB, and 18% of cases of TB that have already been treated globally. Thus, such a strong and increasing rate of cases increases the demand for the diagnostic market and growth in the upcoming years.(Source:https://www.who.int/publications/m/item/multidrug-resistant-tuberculosis-(mdr-tb)#:~:text=Download%20(579.9%20kB)-,Overview,MDR%2FRR%2DTB)
Technological challenges can hamper the growth of the market
Although better diagnostic technologies for tuberculosis are critically needed and becoming more so, there are a few obstacles that could hinder market expansion in the next years. For example, certain technical issues with tuberculosis diagnostics may be a significant barrier to market revenue growth. Furthermore, one of the main factors preventing the market's revenue from growing faster is the greater technical difficulty involved in creating these diagnostic technologies. The most common diagnostic test for tuberculosis, for example, is sputum smear microscopy, albeit it has drawbacks like low sensitivity. Additionally, this could lead to false positive results in other infections like people with HIV for the elderly, and children. Furthermore, it cannot be utilized to rule out tuberculosis extrapulmonary. It is anticipated that the technological complexity associated with tuberculosis diagnostics may hinder the market (Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705651/#:~:text=However%2C%20sputum%20smear%20microscopy%20has,10%2C000%20organisms%2Fml%20sputum%20sample.)
As the outburst of COVID-19 affected the healthcare industry causing more types of diseases. Contrarily, Tuberculosis cases reduced during the pandemic and so the diagnosis market also slowed down. According to the Central TB Division, There has been an overall decline in TB notification by 26% from January to June 2020 as compared to the previous year, due to the COVID-19 pandemic. COVID-19 reduced the rate of testing for Tuberculosis in the global market. For Instance, according to the Global Fund, the number of patients receiving treatment for drug-resistant tuberculosis fell by a startling 19% in 2020 in the countries where the Global Fund makes investments, with a further decline of 37% observed in those receiving treatment for extensively drug-resistant tuberculosis. There was a 16% decrease in the number of HIV-positive TB patients receiving both TB treatment and antiretroviral therapy.(Source:https://www.theglobalfund.org/en/news/2021/2021-09-08-global-fund-results-report-reveals-covid-19-devastating-impact-on-hiv-tb-and-malaria-programs/)Talking about the market of Diagnosis of Tuberculosis, it decreased due to a smaller number of cases. But the symptoms of COVID-19 and Tuberculosis are the same, both are infectious diseases caused by the lungs. COVID-19 is far more dangerous for the health and TB has an incubation period of long and the onset is slower. The number of reports of TB diagnoses is one of the most accessible metrics that may be used to evaluate the effect of COVID-related interruptions on vital TB services at the international, regional, and national levels. This indicator shows how access to diagnosis and treatment is affected by both the supply and demand lockdowns and related movement restrictions, worries about the safety of visiting medical facilities during a pandemic, and the stigma associated with symptoms of tuberculosis and COVID-19 being similar.
We have various report editions of Tuberculosis Diagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Due to the vast number of companies in the market, the tuberculosis market is fairly competitive. The main strategic efforts that the industry players are pursuing include the introduction of new products, partnerships, mergers and acquisitions, and regional expansions. For Instance, SRL Diagnostics introduces an enhanced genetic test for tuberculosis, the largest laboratory network in India. The test is anticipated to provide a comprehensive resistance profiling to eighteen distinct TB medicines and shorten the time required to detect multi-drug resistant tuberculosis.(Source:https://ehealth.eletsonline.com/2022/03/srl-diagnostics-launches-whole-genome-sequencing-test-for-tuberculosis/)
For example, In India, the RNTCP, Revised National Tuberculosis Control Program is a program which focuses on the tuberculosis screening and gives free treatment and diagnosis. These initiatives, drive growth in the market. (Source:https://dghs.gov.in/content/1358_3_RevisedNationalTuberculosisControlProgramme.aspx)
New Innovations like, QIAGEN's QuantiFERON-TB Gold Plus demonstrating the distinct clinical benefit with CD8 technology for recent meta-analysis of tuberculosis screening. Recent developments include, bioMérieux, a global pioneer in in vitro diagnostics, has announced the CE marking of VIDAS TB IGRA (Interferon-Gamma Release Assay), an innovative and fully-automated test for diagnosing latent tuberculosis infection.
Top Companies Market Share in Tuberculosis Diagnostics Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Tuberculosis Diagnostics Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Tuberculosis Diagnostics market.
The current report Scope analyzes Tuberculosis Diagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Tuberculosis Diagnostics Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Tuberculosis Diagnostics Industry growth. Tuberculosis Diagnostics market has been segmented with the help of its Type, Application , and others. Tuberculosis Diagnostics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segmenst performing in Tuberculosis Diagnostics?
Tuberculosis Diagnostics Type Segment Analysis:
On the basis of type of Tuberculosis Diagnosis, it is divided into: radiographic test, laboratory test, nucleic acid test, drug resistant test, detection of latent infection, smear microscopy, culture-based test. and others. The Nucleic Acid test is new and becoming widely available. is the dominating segment in the market. The reason for this is because nuclei acid test has better accuracy than other test of microscopy and even provide the result quickly. The use of nucleic acid amplification tests (NAATs) for tuberculosis are considered more preferable by the World health organisation too. For Instance, According to Pennsylvania department of health, Even in extremely minute quantities, MTBC (Mycobacterium tuberculosis complex) genetic material can be detected by an NAAT in the sample under examination, The results from the NAAT are usually available in a day or two and these fast results provide for better patient outcomes, a shorter infectious period, early treatment beginning, and earlier diagnosis of tuberculosis.(Source: https://www.health.pa.gov/topics/Documents/Diseases%20and%20Conditions/TB/TB%20Insights_NAAT_FINAL_07.26.19.pdf) In hospitals, the test of Smear microscopy, and culture-based tests are found and are good options for people who may not have access to more advanced tests. There are also advances being made in the testing of Tuberculosis. For Instance, Illumina and GenoScreen Partnered up to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis.(Source:https://sapac.illumina.com/company/news-center/press-releases/2022/e692500f-8b9d-420f-8e29-cdded6116e3b.html)
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Tuberculosis Diagnostics Industry. Request a Free Sample PDF!
Tuberculosis Diagnostic Application Segment Anaylsis:
Based on Application, it is divided into two segments: hospitals and diagnostic laboratories. Laboratories are dominating in this market. Hospitals have the diagnosis and testing facilities but if they don’t, the patients are sent to the laboratories. The Diagnostic Laboratories have skilled professionals for the testing of TB. Every laboratory that studies tuberculosis also studies mycobacteriology, and its job is to identify any species of Mycobacterium that might be connected to a disease. Hence, the segment of Tuberculosis Laboratories is more for testing. In the case of pieces of advice or prescriptions from doctors, people go to the hospitals, but in general, both of these segments are interlinked with each other and applicability is seen on various platforms of Healthcare.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Tuberculosis Diagnostics Market is witnessing significant growth in the near future.
In 2023, the Smear Microscopy segment accounted for noticeable share of global Tuberculosis Diagnostics Market and is projected to experience significant growth in the near future.
The Hospital segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Laboratories, Alere Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Smear Microscopy, LF LAM For PLHIV, Culture, Molecular Testing, Drug Susceptibility Testing, Mantoux Tuberculin Testing |
Application | Hospital, Diagnostic laboratories |
List of Competitors | Abbott Laboratories, Becton Dickinson and Company, Alere Inc., BioMerieux SA, F.Hoffmann La Roche AG, Thermo Fisher Scientific, Siemens, Cepheid, Akonni Biosystems, Hain Lifesciences GmBH, NanoEnTe, Hologic Corporation, others |
This chapter will help you gain GLOBAL Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review Global Tuberculosis Diagnostics Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review North America Tuberculosis Diagnostics Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review Europe Tuberculosis Diagnostics Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review Asia Pacific Tuberculosis Diagnostics Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review South America Tuberculosis Diagnostics Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review Middle East Tuberculosis Diagnostics Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Tuberculosis Diagnostics. Further deep in this chapter, you will be able to review Middle East Tuberculosis Diagnostics Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Tuberculosis Diagnostics. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Tuberculosis Diagnostics market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Smear Microscopy have a significant impact on Tuberculosis Diagnostics market? |
What are the key factors affecting the Smear Microscopy and LF LAM For PLHIV of Tuberculosis Diagnostics Market? |
What is the CAGR/Growth Rate of Hospital during the forecast period? |
By type, which segment accounted for largest share of the global Tuberculosis Diagnostics Market? |
Which region is expected to dominate the global Tuberculosis Diagnostics Market within the forecast period? |